| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $170.6M | +76.5% |
| SG&A Expense | $65.4M | +97.8% |
| Operating Income | -$236.0M | -81.9% |
| Pre-tax Income | -$211.8M | -94.3% |
| Income Tax | $361K | +1.7% |
| Net Income | -$212.2M | -94.0% |
| EPS (Basic) | -$6.01 | -51.8% |
| EPS (Diluted) | -$6.01 | -51.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $91.1M | -52.6% |
| Short-term Investments | $700.0M | +135.3% |
| Current Assets | $803.9M | +62.9% |
| Total Assets | $806.9M | +62.4% |
| Current Liabilities | $36.6M | +57.1% |
| Long-term Debt | $29.2M | +3.0% |
| Total Liabilities | $67.1M | +26.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$180.4M | -92.1% |
| Capital Expenditures | $933K | +84.8% |
| Investing Cash Flow | -$394.3M | -34.9% |
| Financing Cash Flow | $473.4M | +116.8% |
| Free Cash Flow | -$181.3M | -92.0% |
| Stockholders' Equity |
| $739.8M |
| +66.8% |